Whereas CD47 is expressed abundantly on LSC in a constitutive manner in most patients with AML and most with CML, the expression of PD-L1 is often weak or absent on LSC in these malignancies. The gene discussed is CD47; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.